Covid-19 Expert Tweets

built by @bhavik_m • support this work
A daily digest of Covid-19 tweets and links you can trust, aggregated from 100s of scientists and experts on Twitter. Learn more about this digest. Follow @CovidExpertList for daily updates. Subscribe to the weekly email digest.

Last updated:
Filter Links & Tweets:

Top Links (last 48h)

Jan 13 • Virological | 12 expert tweets ->
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 Áine O’Toole, MSc1,$,*, Verity Hill, MSc1*, Oliver G. Pybus, DPhil2, Alexander Watts, PhD3,4, Isaac I. Bogoch, MD5,6, Kamran Khan MD, MPH3,4,5, Jane P. Messina, PhD7, The COVID-19 Genomics UK (COG-UK) consortium8, Network for Genomic Surveillance in South...

Jan 13 • Journal of Hospital Infection | 11 expert tweets ->
Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2)
The Covid-19 pandemic has caused untold disruption and enhanced mortality rates around the world. Understanding the mechanisms for transmission of SARS-CoV-2 is key to preventing further spread but there is confusion over the meaning of “airborne” whenever transmission is discussed. Scientific ambivalence originates from evidence published many...

What Does a More Contagious Virus Mean for Schools?
The coronavirus variant discovered in Britain is more easily spread among children, as it is among adults. Current safeguards should protect schools, experts said, but only if strictly enforced.

Jan 14 • Nature Medicine | 10 expert tweets ->
On the origins of SARS-CoV-2
Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.

Jan 13 • The Atlantic | 10 expert tweets ->
The Atlantic Hires Katherine Wu as Staff Writer
Wu joins from The New York Times, and will cover the pandemic

Jan 14 • Science | 9 expert tweets ->
Herd immunity by infection is not an option
Herd immunity is expected to arise when a virus cannot spread readily, because it encounters a population that has a level of immunity that reduces the number of individuals susceptible to infection. On page 288 of this issue, Buss et al. ([ 1 ][1]) describe the extent of the largely uncontrolled severe acute respiratory syndrome coronavirus 2...

Jan 13 • Nature Medicine | 9 expert tweets ->
Immune determinants of COVID-19 disease presentation and severity
The severity of COVID-19 varies by sex and age, and is linked to comorbidities. Differences in immune reactions may go some way to explain this.

Jan 13 • The Atlantic | 8 expert tweets ->
Why Aren’t We Wearing Better Masks?
Cloth masks are better than nothing, but they were supposed to be a stopgap measure.

Jan 14 • Journal of Virology | 8 expert tweets ->
Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection
Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its symptoms has been a pressing area of investigation during the coronavirus disease 2019 (COVID-19) pandemic. Nonsteroidal anti-inflammatory drugs (NSAIDs), which are frequently used for the relief of pain and inflammation, could...

Jan 13 • Cell | 7 expert tweets ->
Messenger RNA vaccines against SARS-CoV-2
The first two vaccines proven to be effective for inhibiting COVID-19 illness were both mRNA, achieving 95% efficacy (and safety) among 74,000 participants (half receiving placebo) after intramuscular delivery of two shots, 3–4 weeks apart. To view this Bench to Bedside, open or download the PDF.

Load More Links (Last 48hrs)

Top Links (last 7 days)

At Elite Medical Centers, Even Workers Who Don’t Qualify Are Vaccinated
Administrators and young graduate students have been inoculated at leading research hospitals, contrary to state and federal guidelines.

Jan 12 • Opinion | 27 expert tweets ->
Opinion | As the New C.D.C. Chief, I’ll Tell You the Truth
Even when the news is bleak.

https://apps.who.int/iris/bitstream/handle/10665/338480/9789240018440-eng.pdf

Jan 08 • Science | 23 expert tweets ->
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
The UK’s COVID-19 epidemic during early 2020 was one of world’s largest and unusually well represented by virus genomic sampling. Here we reveal the fine-scale genetic lineage structure of this epidemic through analysis of 50,887 SARS-CoV-2 genomes, including 26,181 from the UK sampled throughout the country’s first wave of infection. Using...

Jan 10 • medRxiv | 22 expert tweets ->
Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
While several clinical and immunological parameters correlate with disease severity and mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of coronavirus disease 2019 (COVID-19) that can be used to guide clinical practice. Here, we examine saliva and nasopharyngeal (NP) viral load over time and correlate them...

https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586

Jan 09 • STAT | 20 expert tweets ->
We lost to SARS-CoV-2 in 2020. We can defeat B-117 in 2021 - STAT
Humanity wasn't remotely prepared for SARS-Cov-2 when it emerged late in 2019. We are better prepared for the new virus, B-117

Jan 08 • The Lancet | 18 expert tweets ->
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target...

Jan 08 • CNN | 17 expert tweets ->
Exclusive: Biden will release nearly all available vaccine doses in break from Trump administration policy of holding back stock for second dose
President-elect Joe Biden will aim to release nearly every available dose of the coronavirus vaccine when he takes office, a break with the Trump administration's strategy of holding back half of US vaccine production to ensure second doses are available.

The Future of the Coronavirus? An Annoying Childhood Infection
Once immunity is widespread in adults, the virus rampaging across the world will come to resemble the common cold, scientists predict.

Load More Links (Last 7 days)